Caption Management’s Anavex Life Sciences AVXL Stock Holding History

Caption Management’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-60,000	Closed	-$214K	–	1557
2025 Q4	$214K	Hold	60,000	–	–	﹤0.01%	1368
2025 Q3	$534K	Buy	+60,000	New	+$609K	﹤0.01%	1288
2022 Q1	–	Sell	-27,400	Closed	-$475K	–	1456
2021 Q4	$475K	Hold	27,400	–	–	0.01%	1259
2021 Q3	$492K	Sell	27,400 -126,800	-82%	-$2.52M	0.01%	1200
2021 Q2	$3.52M	Buy	+154,200	New	+$2.28M	0.05%	486

Other funds holding AVXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Caption Management's AVXL Position: Q1 2026 in Review

Caption Management sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 354,838 shares — an estimated $1.26M sold.

Caption Management first reported a position in AVXL in Q2 2021 and held it in 2 quarters. The position peaked at $1.67M in Q2 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

Caption Management reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
Caption Management sold 354,838 Anavex Life Sciences shares in Q1 2026, an estimated $1.26M.
Caption Management first reported a position in Anavex Life Sciences in Q2 2021 and held it in 2 quarters.
Caption Management's Anavex Life Sciences position peaked at $1.67M in Q2 2021.
190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.